These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1766577)

  • 1. [The use of reduced glutathione in alcoholic hepatopathy].
    Bresci G; Piccinocchi M; Banti S
    Minerva Med; 1991 Nov; 82(11):753-5. PubMed ID: 1766577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of domestic glutathione on the alcoholic liver disease].
    Zhang Q; Guo S; Hu D; He N; Zhang J; Zhong S; Chen Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):239-40. PubMed ID: 10951629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose reduced glutathione in the therapy of alcoholic hepatopathy].
    Nardi EA; Devito R; Tiburzi F; Ceccanti M
    Clin Ter; 1991 Jan; 136(1):47-51. PubMed ID: 1826873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uridine diphosphate glucose (UDPG) in the treatment of hepatic disease from chronic alcohol abuse].
    Tarantino G; Morelli L; Califano C
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):109-17. PubMed ID: 2080308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyunsaturated phosphatidylcholine + vitamin B complex in the therapy of alcoholic hepatopathies. A controlled study versus standard therapy].
    Hazuka V; Roubal R
    Clin Ter; 1987 Dec; 123(5):369-75. PubMed ID: 2972496
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver.
    Bansal AK; Bansal M; Soni G; Bhatnagar D
    Chem Biol Interact; 2005 Oct; 156(2-3):101-11. PubMed ID: 16144695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A controlled clinical study on the efficacy and tolerability of stepronin in chronic alcoholic liver diseases].
    De Rensis L; Schianchi L; Assunto A; Antenora G; Allocca F; Bossone V
    Clin Ter; 1990 Nov; 135(3):209-13. PubMed ID: 2150022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of the biohumoral picture in alcoholic hepatopathy treated with thiazolidinecarboxylate of arginine].
    Zotti S; Bergamo S; Maddalosso T; Salmi A
    Arch Sci Med (Torino); 1979; 136(3):363-8. PubMed ID: 44995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
    Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
    An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver injury after intermittent or continuous hepatic pedicle clamping and its protection by reduced glutathione.
    Zhou L; Rui JA; Zhou RL; Peng XM; Wang SB; Chen SG; Qu Q; Zhao YP
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):209-13. PubMed ID: 15138111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alcoholic hepatopathy. Aspects of drug therapy].
    Del Dotto M; Neri D
    G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enhancement of antioxidant capability of cancer patients during chemotherapy by reduced glutathione].
    Zhu BD; Li X; Zhao QC; Huang XL
    Ai Zheng; 2004 Apr; 23(4):452-5. PubMed ID: 15087038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine-supplemented diet augments hepatotoxicity and prooxidant status in chronically ethanol-treated rats.
    Yalçinkaya S; Unlüçerçi Y; Uysal M
    Exp Toxicol Pathol; 2007 Aug; 58(6):455-9. PubMed ID: 17498936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lecithin with vitamin-B complex and tocopheryl acetate on long-term effect of ethanol induced immunomodulatory activities.
    Das SK; Gupta G; Rao DN; Vasudevan DM
    Indian J Exp Biol; 2007 Aug; 45(8):683-8. PubMed ID: 17877144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
    Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.